Revenue grew 6.3% to S$118.1m and net profit rose 17.1% to S$122.0m, driven by strong healthcare demand and higher investment income. Gross margin declined due to rising costs, while cash balances fell as investments increased. Persistent cost pressures and global uncertainties may impact future performance.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.